Invention Grant
- Patent Title: Humanized antibodies against human IL-22RA
- Patent Title (中): 针对人IL-22RA的人源化抗体
-
Application No.: US13510068Application Date: 2010-11-12
-
Publication No.: US08545844B2Publication Date: 2013-10-01
- Inventor: Roland Beckmann , Caroline Johnson-Leger
- Applicant: Roland Beckmann , Caroline Johnson-Leger
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serona SA
- Current Assignee: Merck Serona SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP09176525 20091119
- International Application: PCT/EP2010/067332 WO 20101112
- International Announcement: WO2011/061119 WO 20110526
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C12P21/08 ; C12N15/24 ; C07K14/54
Abstract:
The invention relates to humanized antibodies against human IL-22RA and to their use in the treatment of psoriasis and other immune-mediated diseases such as psoriatic arthritis and atopic dermatitis.
Public/Granted literature
- US20120230990A1 HUMANIZED ANTIBODIES AGAINST HUMAN IL-22RA Public/Granted day:2012-09-13
Information query
